Sign up to save your podcasts
Or
Share The Altissimo Study using a TKI for nAMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Altissimo Study using a TKI for nAMD
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
View all episodes
By Retina Synthesis
4.5
88 ratings
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
More shows like Retina Synthesis
View all
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,446 Listeners
The Daily
112,734 Listeners
WSJ Minute Briefing
673 Listeners
Up First from NPR
56,473 Listeners
Bogleheads On Investing Podcast
594 Listeners
MedEdTalks - Ophthalmology
4 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
Talking Euretina
1 Listeners
RetinaRounds™
0 Listeners
The Last Invention
710 Listeners